Janux Therapeutics JANX Total costs & expenses

Total costs & expenses at other companies

AmgenAMGN

$6.54B+0.3%

Regeneron PharmaceuticalsREGN

$3B+15.5%

Nektar TherapeuticsNKTR

$49.92M-9.2%

Vir Biotechnology, Inc.VIR

$165.48M+38.3%

AbbVieABBV

——

FAQ

What is Janux Therapeutics's total costs & expenses?

Janux Therapeutics (JANX) reported total costs & expenses of $41.96M in Q2 2026.

How has Janux Therapeutics's total costs & expenses changed year-over-year?

Janux Therapeutics's total costs & expenses decreased by 7.0% year-over-year, from $45.12M to $41.96M.

What is the long-term trend for Janux Therapeutics's total costs & expenses?

Over 4 years (2021 to 2025), Janux Therapeutics's total costs & expenses has grown at a 46.3% compound annual growth rate (CAGR), from $36.57M to $167.67M.

What does total costs & expenses mean?

This metric represents the aggregate sum of all operating costs incurred by the company during a specific reporting period, including research and development, general and administrative, and other operational outlays. It serves as a primary measure of the total capital required to sustain the company's ongoing business activities and clinical development programs. Monitoring this figure is essential for assessing the company's burn rate and overall operational efficiency in the absence of significant commercial revenue.